Results Wire: US FDA Advisory Committee Supports the FDA’s Plans for New Labeling and Assessment of the Potential Risks With Gadolinium-Based Contrast Agents Report
Results Wire: US FDA Advisory Committee Supports the FDA’s Plans for New Labeling and Assessment of the Potential Risks With Gadolinium-Based Contrast Agents Report